Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy North Carolina woman alleges the recalled tissue marker did not dissolve into her body after breast surgery, resulting in painful complications. April 14, 2025 Irvin Jackson Add Your Comments A breast cancer survivor has filed a BioZorb marker lawsuit after having to undergo a foreign body removal procedure when the implant failed to properly absorb into her body as advertised. The complaint (PDF) was brought by Priscilla McBrayer in the U.S. District Court for the District of Massachusetts on April 4, naming BioZorb’s manufacturer, Hologic, Inc., as the sole defendant. BioZorbs are small implants used during breast cancer treatment. They consist of a biodegradable spacer made from polylactic acid and six permanent titanium clips. Although the BioZorb marker is advertised to gradually break down and dissolve in the body, leaving only the clips in place to mark the location for targeted radiation therapy, women have been complaining for years that they have suffered continuing pain, discomfort and other complications when the device failed to absorb back into the body. Women have also reported issues with BioZorb markers migrated out of position or even protruded painfully through the skin, often resulting in the need for the breast tissue marker to be surgically removed. The number of adverse event reports steadily grew in the years after it was introduced, until the Hologic announced a BioZorb recall in October 2024, recommending that doctors carefully monitor women who still have the marker implanted in their body. Currently, at least 122 plaintiffs are involved in roughly 30 different BioZorb tissue marker lawsuits, raising allegations that are nearly identical to those presented by McBrayer. However, the size of the litigation is expected to grow in the coming months as more women discover that their implants may have failed to dissolve in prior years due to design defects. BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the lawsuit brought by McBrayer, a BioZorb marker was implanted following her diagnosis with breast cancer in 2023. In August of that year she underwent a partial lumpectomy and mastectomy of her right breast, and a BioZorb marker was placed to mark the location for radiation treatment. Despite the implant being properly placed, McBrayer indicates she experienced severe pain, scarring, hardening and dimpling at the implant site. As a result of the complications, she underwent a surgical procedure to remove the BioZorb marker in February 2025. “As a result of the BioZorb implant, Plaintiff has been caused to have significant pain, disfigurement, and worry, leaving her permanently and physically scarred,” the lawsuit states. “Plaintiff’s complications, foreign body reaction, disfigurement, and non-absorption are not warned of on the Instructions for Use but were risks Defendant knew, or should have known, and failed to disclose to physicians and patients.” McBrayer presents claims of design defect, failure to warn, breach of implied warranty, manufacturing defect and negligence. She is seeking both compensatory and punitive damages. April 2025 BioZorb Marker Lawsuits Update McBrayer’s claim will be combined with dozens of others currently consolidated in the District of Massachusetts, where the manufacturer’s headquarters are located and U.S. District Judge Allison D. Burroughs is presiding over coordinated pretrial proceedings and preparing a group of claims for early test trials, which are expected to begin in September 2025. Last month, the court appointed seven plaintiffs’ attorneys to leadership roles in the litigation. This includes two co-lead counsel and a five-member Plaintiffs’ Executive Committee (PEC), who will be responsible for coordinating discovery on common issues, arguing motions before the court, and leading settlement discussions on behalf of all plaintiffs. Each individual plaintiff will still retain their own lawyer to pursue case-specific injury claims and damages. Just days later, Judge Burroughs also rejected a motion to dismiss filed by Hologic, allowing plaintiffs’ design defect claims to proceed. The court found that the complaints sufficiently alleged that the BioZorb marker’s materials, shape and surface texture may prevent proper absorption in the body, leading to migration, infections or painful protrusions. The ruling is expected to apply broadly across the litigation and significantly strengthens the claims moving forward. Tags: BioZorb, BioZorb Recall, Breast Cancer, Hologic More BioZorb Stories Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails May 20, 2025 BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain May 14, 2025 Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries May 5, 2025 Find Out If You Qualify for BioZorb Failure Compensation 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025) Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025) Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain May 14, 2025
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: today) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: yesterday) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Covidien Parietex Optimized Composite (PCOx) Hernia Mesh Lawsuits To Be Prepared for Trial (Posted: yesterday) Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial. MORE ABOUT: HERNIA MESH LAWSUITSecond Bellwether Trial in Covidien Hernia Mesh Lawsuit MDL Set for July 2026 (05/14/2025)Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant (04/10/2025)New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (04/03/2025)